Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2010
12/22/2010CN101925361A Plant-origin drug for preventing or improving hyperuricemia
12/22/2010CN101925356A Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation
12/22/2010CN101925353A VEGFC production promoter
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921726A Oral transformant for immunizing and blocking chicken inhibin and application thereof
12/22/2010CN101921725A Converter for inhibiting hen somatostatin action through oral immunization and application thereof
12/22/2010CN101921319A Rubiaceae-type cyclopeptides, medicinal compositions using same as active ingredients, and preparation method and application thereof
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921225A Pirfenidone compound, preparation method and application thereof
12/22/2010CN101920000A Hot-natured drug
12/22/2010CN101919954A Yam and desertliving cistanche medicinal liquor
12/22/2010CN101919844A Compound for controlling autoimmune disease and use thereof
12/22/2010CN101417041B Traditional Chinese medicine preparation capable of preventing and treating coronary heart disease angina, heat-stroke abdomen pain, heart and abdomen pain
12/22/2010CN101284041B Compound radix astragali Chinese medicinal formulations with health-care function
12/22/2010CN101264051B Modified release pharmaceutical formulation
12/22/2010CN101048406B Novel substituted imidazole derivatives
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
12/21/2010US7855222 indazole derivatives such as 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, used for the treatment of vision defects
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
12/21/2010US7855056 Antibody against tumor specific antigen as target
12/21/2010US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides
12/21/2010CA2494024C Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide,the preparation thereof and their use as pharmaceutical compositions
12/21/2010CA2492718C Prodrugs of proton pump inhibitors
12/21/2010CA2483461C Isoquinoline derivatives
12/21/2010CA2483345C Imidazolinylmethyl aralkylsulfonamides
12/21/2010CA2477885C Pressurised metered dose inhalers containing solutions of beta-2 agonists
12/21/2010CA2464130C Mch antagonists for the treatment of obesity
12/21/2010CA2452596C Benzo-fused 5-membered heterocyclic compounds, their production and use
12/21/2010CA2444395C Use of nk-1 receptor antagonists against benign prostatic hyperplasia
12/21/2010CA2444130C Adenine derivatives
12/21/2010CA2441386C Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/21/2010CA2412004C Glucagon-like peptide-1 analogs
12/21/2010CA2411981C Urokinase inhibitors
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/21/2010CA2395100C Substituted sapogenins and their use
12/21/2010CA2369895C High affinity inhibitors for target validation and uses thereof
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/21/2010CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
12/21/2010CA2294924C Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2220753C Novel peptides and compositions which modulate apoptosis
12/16/2010WO2010144535A1 Methods and compositions for the induction of hypothermia
12/16/2010WO2010143939A1 Nutrition for improving muscle strength in elderly
12/16/2010WO2010143714A1 Aptamer for chymase, and use thereof
12/16/2010WO2010143708A1 Targeting agent for neovascularization
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010143661A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
12/16/2010WO2010143582A1 Phenylcyclopropylamine derivatives and lsd1 inhibitors
12/16/2010WO2010143170A2 Compounds useful for treating premature aging and in particular progeria
12/16/2010WO2010143169A2 Compounds useful for treating aids
12/16/2010WO2010143168A2 Compounds useful for treating cancer
12/16/2010WO2010143101A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals.
12/16/2010WO2010142761A1 The succinate of tenofovir disoproxil
12/16/2010WO2010142696A1 Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
12/16/2010WO2010142216A1 PYRAZOLO-[1,5-a]-PYRIMIDONES DERIVATES AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
12/16/2010US20100318003 Method and Apparatus for Connective Tissue Treatment
12/16/2010US20100317728 Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317693 3,8-diaminotetrahydroquinoline derivative
12/16/2010US20100317690 Treatment of protein folding disorders
12/16/2010US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317599 Process for the production of a peptide
12/16/2010US20100317595 Compositions for enhancing nail growth
12/16/2010US20100317581 Ipamorelin Diacetate Injection and Infusion Solutions
12/16/2010US20100317101 Culture System for Rapid Expansion of Human Embryonic Stem Cells
12/16/2010US20100316735 Compositions and methods for reducing hangover symptoms
12/16/2010US20100316723 Compositions and methods for treating inflammation
12/16/2010US20100316715 Chitosan composition
12/16/2010US20100316710 Sustained-release tablet composition of pramipexole
12/16/2010US20100316707 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316705 System for exsanguinous metabolic support of an organ or tissue
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316701 Compositions and method for manipulating pim-1 activity in circulatory system cells
12/16/2010US20100316688 Methods for culturing stem and progenitor cells
12/16/2010US20100316612 Primed cell therapy
12/16/2010US20100316610 Mutant having uracil phosphoribosyl transferase activity
12/16/2010US20100316570 Protection of Virus from Immune Cell Uptake
12/16/2010CA2764807A1 Methods and compositions for the induction of hypothermia
12/16/2010CA2764782A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2764472A1 Aptamer for chymase, and use thereof
12/16/2010CA2764027A1 Compounds useful for treating premature aging and in particular progeria
12/16/2010CA2764026A1 Compounds useful for treating aids
12/15/2010EP2261331A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261214A1 Compounds useful to treat premature aging and in particular progeria
12/15/2010EP2261213A1 Heterocyclic compound
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 1564